Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2 (Nature Communications, 2022)

(untitled) - Hermosilla, E; Coma, E; Xie, J; Feng, S; Cabezas, C; Méndez-Boo, L; Fina, F; Ballo, E; Martínez, M; Medina-Peralta, M; Argimon, JM; Prieto-Alhambra, D